srch

Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. finance.yahoo ...

Oct 04, 2022 · CLEVELAND, October 04, 2022--Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today their ...

A high-level overview of Athersys, Inc. (ATHX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment ...

2 päivää sitten · Athersys, Inc. Announces $12 Million Registered Direct Offering. CLEVELAND, August 15, 2022--Athersys, Inc. (Nasdaq: ATHX) today announced that it has entered into a …

27.9.2022 · businesswire.com - June 21 at 11:00 AM. Athersys shares rebound somewhat since falling by two-thirds on clinical trial results - The Business Journals. bizjournals.com - June 17 …

Readers are urged to refer to the most recent press release and SEC ... Athersys Reports Second Quarter 2022 Financial Results and Provides Business Update.

Get the latest Athersys, Inc. (ATHX) stock news and headlines to help you in your trading and investing decisions.

10.5.2018 · For Athersys, its most recent earnings (trailing twelve month) is -US$32.24M, which, in comparison to the previous year’s figure, has become more negative. Since these figures are …

Mar 15, 2022 · Management to host conference call at 4:30 pm ET today; Dan Camardo, newly appointed Chief Executive Officer, will lead the call and share his initial perspective on the path to commercial success for the Company Athersys, Inc. (Nasdaq: ATHX) announced today its financial results for the three months and full year ended December 31, 2021, along with a corporate update. Daniel A. Camardo ...

“We are pleased to have entered into this amendment with our new major investor which provides more financial flexibility going forward as well ...

4.10.2022 · CLEVELAND, October 04, 2022--Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, …

Get the latest Athersys, Inc. (4LS.F) stock news and headlines to help you in your trading and investing decisions.

CLEVELAND, August 11, 2022--Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three and six months ended June 30, 2022 and provided a ...

Get the latest Athersys, Inc. (ATHX) stock news and headlines to help you in your trading and investing decisions.

14 Nov 2022 / 2:59 AM PSTQ3 2022 Athersys Inc Earnings Release ... Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes ...

Oct 06, 2022 · According to analysts' consensus price target of $6.25, Athersys has a forecasted upside of 276.5% from its current price of $1.66. Amount of Analyst Coverage Athersys has received no research coverage in the past 90 days. See Top Rated MarketRank™ Stocks Here About Athersys (NASDAQ:ATHX) Stock

12.8.2022 · Financial Athersys Reports Second Quarter 2022 Financial Results and Provides Business Update. Shared by Ken Dropiewski on August 12, 2022. ... We are a website dedicated …

Get Athersys Inc (ATHX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Latest Trade. trading higher 1.63 USD. Change 0 % Change ... About Athersys Inc (ATHX.OQ) ... Access unmatched financial data, news and content in a highly-customised workflow …

24.3.2022 · Find the latest news headlines from Athersys, Inc. Common Stock (ATHX) ... Financials; Earnings; P/E ... Here you can find up-to-the-minute news and analysis of the …

23.9.2022 · Find the latest news for Athersys Stock on our page and stay on top of the game. ... Athersys to Host Year-End 2021 Financial Results Call; New CEO, Daniel A. Camardo, ...

Here you can find the company's latest financial figures, contact information, and source version of the press release to stay ahead of the market for value ...

At Athersys, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.